About the Cancer Biomarkers Session
Cancer biomarkers serve as crucial compasses in the realm of cancer research, providing pivotal clues into diagnosis, prognosis, and treatment efficacy. These biological indicators encompass a diverse array of molecules—ranging from proteins to genes—found in bodily fluids, tissues, or blood. Their analysis enables the detection of cancer at earlier stages, prognostication of disease trajectory, and customization of treatment plans tailored to individual patients. Recent strides in technology, such as genomic sequencing and liquid biopsies, have significantly augmented the precision and scope of biomarker identification. Moreover, ongoing investigations are dedicated to unearthing novel biomarkers capable of revolutionizing early detection methods and enhancing patient outcomes, thus charting a promising course toward personalized cancer management.
Topics Covered in Cancer Biomarkers
Diagnostic Markers
Prognostic Signatures
Predictive Biomarkers
Serum Tumor Markers
Liquid Biopsy
Assay Validation
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Biomarkers Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Biomarkers work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Biomarkers research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Biomarkers track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Biomarkers Conference 2027 — FAQs
What is the Cancer Biomarkers track at CIOC 2027?
The Cancer Biomarkers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Biomarkers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Biomarkers sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Biomarkers are all welcome — whether presenting or attending.
Can I present my research in the Cancer Biomarkers track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Biomarkers sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Biomarkers track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.